VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ A diagnosis of VTE in outpatient clinic or as      │ A diagnosis of VTE in outpatient clinic or as      │     100 │
│ discharge diagnosis after hospitalization          │ discharge diagnosis after hospitalization          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ A claimed prescription of a NOAC from a Danish     │ A claimed prescription of a NOAC from a Danish     │     100 │
│ pharmacy within 14 days of discharge or outpatient │ pharmacy within 14 days of discharge or outpatient │         │
│ clinic visit                                       │ clinic visit                                       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ A prescription of a NOAC within 90 days prior to   │ A prescription of a NOAC within 90 days prior to   │     100 │
│ hospitalization or outpatient clinic visit for VTE │ hospitalization or outpatient clinic visit for VTE │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients with NOAC preference apart from           │ Patients with NOAC preference apart from           │     100 │
│ preference consistent with current cluster         │ preference consistent with current cluster         │         │
│ randomized NOAC                                    │ randomized NOAC                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Other contraindications mentioned in the "Summary  │ Other contraindications mentioned in the "Summary  │     100 │
│ of Product Characteristics" for the respective     │ of Product Characteristics" for the respective     │         │
│ NOAC                                               │ NOAC                                               │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Your personal trial has no unique criteria

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 100
Average Levenshtein Ratio of individual lines: 100.0
OverAll Ratio: 100.0
